Identification of “Hot Spots” in Druggable Binding Pockets by Computational Solvent Mapping of Proteins Melissa R. Landon 1, Jessamin Yu 1, Spencer C.

Slides:



Advertisements
Similar presentations
Improving Gleevec: Insight from the Receptor Structure Gleevec cannot bind to the open (active) form of the Abl kinase - would collide with open conformation.
Advertisements

Improving enrichment rates A practical solution to an impractical problem Noel O’Boyle Cambridge Crystallographic Data Centre
Bioinformatics Vol. 21 no (Pages ) Reporter: Yu Lun Kuo (D )
Background Goals Methods Results Conclusions Implications.
Molecular dynamics refinement and rescoring in WISDOM virtual screenings Gianluca Degliesposti University of Modena and Reggio Emilia Molecular Modelling.
Two Examples of Docking Algorithms With thanks to Maria Teresa Gil Lucientes.
S. Vajda, 2005 Computational mapping of proteins for fragment based drug design Sandor Vajda, Spencer Thiel, Michael Silberstein, Melissa Landon, and David.
QM/MM Study of Cytochrome P450 BM3 Catalysis Mechanism and Application in Drug Design.
S. Vajda, 2005 Computational Mapping of Proteins for Exploring the Role of Binding Site Plasticity in Molecular Recognition and Information Transfer Karl.
An Integrated Approach to Protein-Protein Docking
BL5203: Molecular Recognition & Interaction Lecture 5: Drug Design Methods Ligand-Protein Docking (Part I) Prof. Chen Yu Zong Tel:
Molecular Docking Using GOLD Tommi Suvitaival Seppo Virtanen S Basics for Biosystems of the Cell Fall 2006.
Module 2: Structure Based Ph4 Design
Max Shokhirev BIOC585 December 2007
ClusPro: an automated docking and discrimination method for the prediction of protein complexes Stephen R. Comeau, David W.Gatchell, Sandor Vajda, and.
Structural Bioinformatics R. Sowdhamini National Centre for Biological Sciences Tata Institute of Fundamental Research Bangalore, INDIA.
02/03/10 CSCE 769 Dihedral Angles Homayoun Valafar Department of Computer Science and Engineering, USC.
Modelling binding site with 3DLigandSite Mark Wass
 Four levels of protein structure  Linear  Sub-Structure  3D Structure  Complex Structure.
DE NOVO DESIGN OF A THYMIDYLATE KINASE INHIBITOR.
Protein Structure Modelling Many sequences - few structures Homology Modelling - Based on Sequence Similarity with Sequences of Known Structures.
BL5203 Molecular Recognition & Interaction Section D: Molecular Modeling. Chen Yu Zong Department of Computational Science National University of Singapore.
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
SimBioSys Inc.© Slide #1 Enrichment and cross-validation studies of the eHiTS high throughput screening software package.
A Technical Introduction to the MD-OPEP Simulation Tools
Patentability Considerations in the 3-D Structure Arts Patentability Considerations in the 3-D Structure Arts Michael P. Woodward Supervisory Patent Examiner.
Altman et al. JACS 2008, Presented By Swati Jain.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Enrico Spiga 1,2 Andrea Scorciapino 1, Arturo Robertazzi 1, 2, Roberto Anedda 2, Mariano Casu 2, Paolo Ruggerone 1 and Matteo Ceccarelli 1 1 University.
Ensemble Approaches Yield New Scaffolds and New Binding Sites Heather A. Carlson Department of Medicinal Chemistry College of Pharmacy University of Michigan.
Molecular dynamics simulations of toxin binding to ion channels Quantitative description protein –ligand interactions is a fundamental problem in molecular.
Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine Ajay N. Jain UCSF Cancer Research Institute and Comprehensive.
Mean Field Theory and Mutually Orthogonal Latin Squares in Peptide Structure Prediction N. Gautham Department of Crystallography and Biophysics University.
Molecular mechanics Classical physics, treats atoms as spheres Calculations are rapid, even for large molecules Useful for studying conformations Cannot.
Mechanism of Curcumin Inhibiting Amyloid-  Peptides Aggregation by Molecular Dynamics Simulations Zhenyu Qian, and Guanghong Wei State Key Laboratory.
Elon Yariv Graduate student in Prof. Nir Ben-Tal’s lab Department of Biochemistry and Molecular Biology, Tel Aviv University.
Molecular Modeling in Drug Discovery: an Overview
Creation Of Novel Compounds by Evaluation of Residues at Target Sites
Rong Chen Boston University
Origin of Cooperativity
Systems-Based Design of Bi-Ligand Inhibitors of Oxidoreductases
Protein Structure Prediction and Protein Homology modeling
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Virtual Screening.
Comparison of Cg-OxyR active-site pocket with previously published structures. Comparison of Cg-OxyR active-site pocket with previously published structures.
Ligand Docking to MHC Class I Molecules
An Integrated Approach to Protein-Protein Docking
AnchorDock: Blind and Flexible Anchor-Driven Peptide Docking
Systems-Based Design of Bi-Ligand Inhibitors of Oxidoreductases
William J. Zuercher, Jonathan M. Elkins, Stefan Knapp 
Volume 4, Issue 3, Pages (March 1996)
Volume 15, Issue 1, Pages (January 2007)
G. Fiorin, A. Pastore, P. Carloni, M. Parrinello  Biophysical Journal 
Binding Dynamics of Isolated Nucleoporin Repeat Regions to Importin-β
Volume 90, Issue 1, Pages (July 1997)
Ligand Binding to the Voltage-Gated Kv1
Volume 21, Issue 6, Pages (June 2013)
The basis for K-Ras4B binding specificity to protein farnesyl-transferase revealed by 2 Å resolution ternary complex structures  Stephen B Long, Patrick.
The Structural Basis of Peptide-Protein Binding Strategies
Volume 7, Issue 7, Pages (July 2000)
Atomistic Simulations of Viral Insulin Like and Insulin Mimetic Peptides Evan Redfearn and Dr. Harish Vashisth Department of Chemical Engineering, University.
ORGANIC PHARMACEUTICAL CHEMISTRY IV
Volume 20, Issue 1, Pages (January 2012)
Insights from Free-Energy Calculations: Protein Conformational Equilibrium, Driving Forces, and Ligand-Binding Modes  Yu-ming M. Huang, Wei Chen, Michael J.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Volume 4, Issue 3, Pages (March 1996)
Volume 15, Issue 6, Pages (September 2004)
Presentation transcript:

Identification of “Hot Spots” in Druggable Binding Pockets by Computational Solvent Mapping of Proteins Melissa R. Landon 1, Jessamin Yu 1, Spencer C. Thiel 2, David R. Lancia 2, Jr., Sandor Vajda 1,3 1 Bioinformatics Graduate Program, Boston University, Boston MA 2 SolMap Pharmaceuticals, Cambridge MA 3 Department of Biomedical Engineering, Boston University, Boston MA

Terms Druggability: the ability of a protein’s binding pocket(s) to bind lead-like molecules with high affinity Hot Spots: specific residues within a binding pocket for which ligands display high affinity

Protein mapping and druggability Hajduk PJ, Huth JR, Fesik SW: Druggability indices for protein targets derived from NMR-based screening data. J Med Chem (2005) 48(7): Hajduk PJ, Huth JR, Tse C: Predicting protein druggability. Drug Discov Today (2005) 10(23-24): Observation based on SAR by NMR: Druggable sites bind a variety of small molecules Binding of probes is restricted to ligand binding sites “Hit rate” in mapping is a predictor of druggability

CS-Map is based on an experimental method for ligand binding site identification by the co-crystallization of a protein in multiple organic solvents C. Mattos and D. Ringe. Nature Biotech. 14: (1996) CS-Map: Introduction

Step 1A: Probe Placement 222 initial probe positions

Steps 1B-2: Rigid Body Search and Minimization Simplex search Free energy-based score Second minimization in CHARMM includes Van der Waal term

Step 3: Clustering of Bound Probes Interaction-based clustering

Step 4: Creation of Consensus Sites 5-10 lowest free energy clusters for each probe used

Example 1: Mapping of lysozyme Binding of solvents to lysozyme (Liepinsh & Otting, 1997) NMR data on the binding of methanol, isopropanol, acetone, acetonitrile, t-butanol, urea, DMSO, and methylene chloride Based on observed NOEs:  All ligands bind at site C 9 NOEs: N59 NH, W63 C  H, W63 N  H, I98 C  H, I98 C  H, A107 C  H, W108 C  H, W108 C   W108 N  H  In addition to site C, methanol and methylene chloride bind to an internal site  A few week NOEs for isopropanol and acetone show binding at the rim of site C

Dennis, S., Kortvelyesi T., and Vajda. S. Computational mapping identifies the binding sites of organic solvents on proteins. Proc. Natl. Acad. Sci. USA., 99: , Kortvelyesi, T., Dennis, S., Silberstein, M., Brown III, L., and Vajda, S. Algorithms for computational solvent mapping of proteins. Proteins. 51: , 2003.

Lowest free energy clusters for eight ligands Methanol Isopropanol Acetone Tert-butanol Urea DMSO Acetonitrile Methylene chloride A107 I98 W108 W63 N59

Subclusters of methanol and isopropanol methanol N59 Q57 W63 I98 W108 A107 W108 A107 isopropanol N59 Q57 W63 I98

Conclusions I: The nature of binding sites Each ligand binds in several rotational states. The van der Waals energy is low in each rotational state: a well defined pocket that can burry the ligands and exclude water The site includes a hydrophobic patch created by hydrophobic side chains The site also includes several hydrogen bond donor or acceptor groups: (for lysozyme N59 NH, W62 N  H, W63 N  H, A107 O, and Q57 O)

Example 2: Thermolysin Probes: Isopropanol (IPA) Acetone (ACN) Acetonitrile (CCN) Phenol (IPH) All in the S ’ 1 pocket Experimental mapping English, et al. Proteins 37, (1999) Protein Eng. 14, (2001).

Thermolysin – Computational Mapping Consensus sites 1 and 2 Obtained by the CS-Map algorithm Dennis, S., Kortvelyesi T., and Vajda. S. Computational mapping identifies the binding sites of organic solvents on proteins. Proc. Natl. Acad. Sci. USA., 99: , Kortvelyesi, T., Dennis, S., Silberstein, M., Brown III, L., and Vajda, S. Algorithms for computational solvent mapping of proteins. Proteins. 51: , 2003.

Comparison of mapping results to contacts in the PDB

Hydrogen bonds in thermolysin

Textbook-type representation of H- Bonds

Why does CS-Map give better results than earlier methods ? 1.Improved sampling of the regions of interest 2.A scoring potential that accounts for desolvation 3.Clusters are ranked, not individual conformations 4.Consensus site: The binding of different solvents reduces the probability of finding false positives

Detection of Hot Spots within Druggable Binding Pockets by CS-Map Purpose of study: To determine the predictive power of CS-Map toward the identification of hot spots within a binding pocket Comparisons are based on known ligand interactions and NMR data

Part 1: Identification of hot spots in peptide binding pocket of Renin Major target for the treatment of hypertension Over 25 years of research into small molecule inhibitors Most inhibitors are peptidomimetics Novartis in Phase III trials of Aliskiren, a novel non- peptidomimetic renin inhibitor

Part 1: Identification of hot spots in peptide binding pocket of Renin First orally available inhibitor, Aliskiren, binds in a different conformation than peptidomimetic inhibitors - Wood, JM. et. al. Biochem. Biohphys. Res. Commun. 308(4): (2003 Used the GOLD algorithm for docking -Verdonk, M.L, et. al. Proteins. 52: (2003)

Identification of Peptide Binding Pocket by CSMap Top two consensus sites for each structure are located in the binding pocket 1RNE 1BIL 1BIM 1HRN 2REN

Identification of Preferred Binding Modality of Aliskiren using CSMap S4 S2 S3 S1 S1’ S2’ S3SP

CS-Map Based Identification of Hot Spots in Peptide Binding Pocket of Renin Atom-Based Interactions calculated using HBPlus I.K. McDonald and J.M.Thornton. J. Mol. Biol. 238: (1994) Pearson Correlation between Probes & Aliskiren =.73 Pearson Correlation between Probes & Peptidomimetic =.17 S3SP S1 S2’ S1 S2 S3 S1 S2 S4 S1’

Conclusions IV Mapping results indicate the druggable pockets in the renin active site Pockets S2 and S4 are not “hot spots” and should not be targeted. The most important pockets are S1 and S3 Pockets S1’ and S2’ are of intermediate importance, but contribute to the binding. Some of these regions, primarily S2’, is not utilized by Aliskiren, suggesting that a higher affinity drug may be developed. Conclusions: Part 1

Ketopantoate Reductase NMR studies of E.coli Ketopantoate Reductase using NADPH fragments and co-factor analogues revealed two hot spots located on opposite ends of the NADPH binding region -Ciulli, et. al. J.Med. Chem Vol. 49 Mutational analysis of residues on opposite ends of the binding region, R31 and N98, confirmed these results. *Figures reproduced from Ciulli, et. al.

Mapping Results: Ketopantoate Reductase CS-Map Results (% Interaction/Residue): Red: 4.15/residue Green: 4.13/residue White: 2.52/residue Blue: 4.63/residue N98 R31 Mapping analysis of three structures, PDB IDs 1YJQ, 1YON, 1KS9, yielded hot spots on either end of the NADPH binding region, in agreement with the experimental study

Part 2: Hot Spot Identification for Proteins used in NMR druggability study *Verified by structural and/or NMR data NMR study published by Hajduk, et. al. J. Med Chem. 2005

Example from Study: FK-506 Binding Protein Important Target for Immunosuppression CS-Map Results Correspond to NMR data Shuker, S.B., et. al. Science 274(5292): (1996)

Comparison of Residue Interactions between CS-Map Probes and Bound Ligands

Conclusions: Part 2 CS-Map is capable of determining hot spots within binding pockets of druggable proteins, supported both by NMR and structural data

General Conclusions and Future Directions The computational prediction of residues important for ligand binding is crucial to structure-based drug design efforts, as well as providing further insight into protein-ligand interactions. Future work will focus on the use of CS-Map derived data to predict hot spots on proteins for which no experimental binding data exists, namely to build pharmacophore models of ligand interactions and to predict hydrogen bonding patterns.

Many Thanks The Vajda Group: Melissa Landon Karl Clodfelter Jessamin Yu Spencer Thiel David Lancia, Jr. SolMap Pharmaceuticals: Frank Guarnieri Patrick Devaney This work was funded by National Institutes of Health SolMap Pharmaceuticals